Skip to main content Back to Top
Advertisement

10/4/2019

Prednisone Oral Tablets

Products Affected - Description

    • Prednisone oral tablet, Cadista, 1 mg, bottle, 100 count, NDC 59746-0171-06
    • Prednisone oral tablet, Cadista, 1 mg, bottle, 1000 count, NDC 59746-0171-10
    • Prednisone oral tablet, Cadista, 10 mg, bottle, 100 count, NDC 59746-0173-06
    • Prednisone oral tablet, Cadista, 10 mg, bottle, 500 count, NDC 59746-0173-09
    • Prednisone oral tablet, Cadista, 10 mg, bottle, 1000 count, NDC 59746-0173-10
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 100 count, NDC 59746-0175-06
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 500 count, NDC 59746-0175-09
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 1000 count, NDC 59746-0175-10
    • Prednisone oral tablet, Cadista, 5 mg, bottle, 100 count, NDC 59746-0172-06
    • Prednisone oral tablet, Cadista, 5 mg, bottle, 1000 count, NDC 59746-0172-10
    • Prednisone oral tablet, Hikma, 1 mg, bottle, 100 count, NDC 00054-4741-25
    • Prednisone oral tablet, Hikma, 1 mg, bottle, 1000 count, NDC 00054-4741-31
    • Prednisone oral tablet, Hikma, 1 mg, unit-dose blister pack, 100 count, NDC 00054-8739-25
    • Prednisone oral tablet, Hikma, 10 mg, bottle, 100 count, NDC 00054-0017-25
    • Prednisone oral tablet, Hikma, 10 mg, bottle, 500 count, NDC 00054-0017-29
    • Prednisone oral tablet, Hikma, 10 mg, unit-dose blister pack, 100 count, NDC 00054-0017-20
    • Prednisone oral tablet, Hikma, 2.5 mg, unit-dose blister pack, 100 count, NDC 00054-8740-25
    • Prednisone oral tablet, Hikma, 20 mg, bottle, 100 count, NDC 00054-0018-25
    • Prednisone oral tablet, Hikma, 20 mg, bottle, 500 count, NDC 00054-0018-29
    • Prednisone oral tablet, Hikma, 20 mg, unit-dose blister pack, 100 count, NDC 00054-0018-20
    • Prednisone oral tablet, Hikma, 5 mg, bottle, 100 count, NDC 00054-4728-25
    • Prednisone oral tablet, Hikma, 5 mg, bottle, 1000 count, NDC 00054-4728-31
    • Prednisone oral tablet, Hikma, 5 mg, unit-dose blister pack, 100 count, NDC 00054-8724-25
    • Prednisone oral tablet, Hikma, 50 mg, bottle, 100 count, NDC 00054-0019-25
    • Prednisone oral tablet, Hikma, 50 mg, unit-dose blister pack, 100 count, NDC 00054-0019-20
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 100 count, NDC 00603-5339-21
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 1000 count, NDC 00603-5339-32
    • Prednisone oral tablet, Teva, 10 mg, bottle, 100 count, NDC 00591-5442-01
    • Prednisone oral tablet, Teva, 10 mg, bottle, 1000 count, NDC 00591-5442-10
    • Prednisone oral tablet, Teva, 10 mg, unit-dose blister pack, 21 count, NDC 00591-5442-21
    • Prednisone oral tablet, Teva, 10 mg, unit-dose blister pack, 48 count, NDC 00591-5442-43
    • Prednisone oral tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-5443-01
    • Prednisone oral tablet, Teva, 20 mg, bottle, 500 count, NDC 00591-5443-05
    • Prednisone oral tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-5443-10
    • Prednisone oral tablet, Teva, 5 mg, unit-dose blister pack, 21 count, NDC 00591-5052-21
    • Prednisone oral tablet, Teva, 5 mg, unit-dose blister pack, 48 count, NDC 00591-5052-43

Reason for the Shortage

    • Cadista, Hikma, and Par did not provide a reason for the shortage.
    • Teva has prednisone 5 and 10 mg tablets in 21 and 48 count packaging on shortage due to manufacturing delays.

Available Products

    • Prednisone oral tablet, Hikma, 2.5 mg, bottle, 100 count, NDC 00054-4742-25
    • Prednisone oral tablet, Par Pharmaceuticals, 1 mg, bottle, 100 count, NDC 00603-5335-21
    • Prednisone oral tablet, Par Pharmaceuticals, 1 mg, bottle, 1000 count, NDC 00603-5335-32
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 100 count, NDC 00603-5338-21
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 500 count, NDC 00603-5338-28
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 1000 count, NDC 00603-5338-32
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, unit-dose blister pack, 21 count, NDC 00603-5338-15
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, unit-dose blister pack, 48 count, NDC 00603-5338-31
    • Prednisone oral tablet, Par Pharmaceuticals, 2.5 mg, bottle, 100 count, NDC 00603-5336-21
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 500 count, NDC 00603-5339-28
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, bottle, 100 count, NDC 00603-5337-21
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, bottle, 1000 count, NDC 00603-5337-32
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, unit-dose blister pack, 21 count, NDC 00603-5337-15
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, unit-dose blister pack, 48 count, NDC 00603-5337-31
    • Prednisone oral tablet, Teva, 10 mg, bottle, 500 count, NDC 00591-5442-05
    • Prednisone oral tablet, Teva, 5 mg, bottle, 100 count, NDC 00591-5052-01
    • Prednisone oral tablet, Teva, 5 mg, bottle, 1000 count, NDC 00591-5052-10

Estimated Resupply Dates

    • Cadista has all prednisone tablet presentations on allocation.
    • Hikma has most prednisone tablet presentations on allocation.
    • Par has prednisone 20 mg tablets in 100 and 1000 count bottles on back order and the company estimates a release date of mid-October 2019.
    • Teva has prednisone 5 mg and 10 mg tablets in 21 and 48 count bottles on back order and the company estimates a release date of early-November 2019. Prednisone 10 mg and 20 mg tablets in 100 and 1000 count bottles are on back order and the company estimates a release date of late-October 2019.

Updated

Updated October 4, 2019 by Rachael Freeman, PharmD, BCPS. Created May 15, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins